 | Erasca, Inc. | |||
| NMS : ERAS || Location: United States | ||||
$1.79-0.05 (-2.72%) |
0.65 M | 1.76 - 1.87 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 8.865 M |
| March 15, 2024 | 9.025 M |
| Feb. 29, 2024 | 9.898 M |
| Feb. 15, 2024 | 10.272 M |
| Jan. 31, 2024 | 10.218 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.23 | -0.20 | 13.68% |
| 09/30/2023 | -0.22 | -0.20 | 10.87% |
| 06/30/2023 | -0.24 | -0.21 | 12.75% |
| 03/31/2023 | -0.32 | -0.22 | 31.31% |
| 12/31/2022 | -0.33 | -1.06 | -224.75% |
ERAS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 151.494M | Shares Float | 85.721M |
| Short Float | 8.865M | Market Cap | 271.17M |
| Institution ownership | 47.49% | Insider ownership | 20.335% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.83 | Forward EPS | -0.99 |